Hitesh Bhai, what is your view on Marksans Pharma for long term? It’s foray in low competition niche Softgel segment looks attractive because it will help the company to survive in highly competitive regulated market like US. Strategic acquisition of Time CAP Lab will increase its front end presence in US because Products of Marksans will also be sold via Time-Cap channels. Now they are also is likely to strong their foothold in Germany , largest market in Europe by FY17. Management remains upbeat on revenue growth of 30% in coming few years. Valuation is the only major concern
| Subscribe To Our Free Newsletter |
